PTAB

IPR2020-00040

Mylan Pharmaceuticals Inc v. Merck Sharp & Dohme Corp

General

Filed

10/30/19

Institution05/12/20

FWD--

Close05/07/21

StatusFinal Written Decision

OutcomePatentable

Appeals

Administrative Patent Judges

Judge	Cases	Inst. Rate	FWD Inv. Rate
Roberta Pollock	400+	67%	67%
Sheridan K Snedden	500+	62%	71%
Timothy G Majors	100+	75%	45%

Petitioner

Party

Name	Ratings
Mylan Pharmaceuticals Inc	L5 A
DR Reddys Laboratories Inc	L4 C
Sun Pharmaceuticals Industries Ltd	L3 A
DR Reddy's Laboratories Ltd	L3 C

No Parties

Attorney

Name	Ratings
Winston & Strawn LLP	L5 A
Jovial Wong	L3 A
Goodwin Procter LLP	L5 E
Keith A. Zullow	L1 C
Lerner David Littenberg Krumholz & Mentlik LLP	L4 C
Michael H. Teschner	L4 E
Tedd W. van Buskirk	L3 A
Russell W. Faegenburg	-- -- --
Katten Muchin Rosenman LLP	L2 E
Jitendra Malik	L3 E
Christopher West	L1 C
Lance Soderstrom	-- -- --
Alissa M. Pacchioli	-- -- --

No Attorneys

Respondent

Party

Name	Ratings
Merck Sharp & Dohme Corp	L4 B

No Parties

Attorney

No Attorneys